News Image

What's going on in today's pre-market session

By Mill Chart

Last update: Feb 3, 2023

Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.

Pre-market gainers

TickerChangeComment
GENE174.0%GENETIC TECH LTD-SP ADR's (NASDAQ:GENE) stock price increased by 174.0% to $2.77. A press release (GENE to Launch World’s First Comprehensive Risk Test for Breast & Ovarian Cancer) was released earlier today.
RSLS138.0%RESHAPE LIFESCIENCES INC's (NASDAQ:RSLS) shares rose 138.0% to $15.0 during Friday's pre-market session. In the last month the stock lost 29.21%.
MGTA54.83%MAGENTA THERAPEUTICS INC's (NASDAQ:MGTA) shares rose 54.83% to $0.87 during Friday's pre-market session. In the last month the share price increased with 29.11%.
GRCL30.05%GRACELL BIOTECHNOLOGIES-ADR (NASDAQ:GRCL) rose 30.05% to $2.77 during Friday's pre-market session. The stock is trading 40.67% lower than 3 months ago.
JWN27.77%NORDSTROM INC's (NYSE:JWN) shares rose 27.77% to $27.01 during Friday's pre-market session. Shareholders saw the stock price going 27.2% higher in the past month.
SIDU19.43%SIDUS SPACE INC-CL A's (NASDAQ:SIDU) shares rose 19.43% to $0.48. Yesterday the company had a press release: Sidus Space, Inc. Announces Closing of $5.2 Million Public Offering and Full Exercise of Underwriters’ Over-Allotment Option.
BGXX18.87%BRIGHT GREEN CORP (NASDAQ:BGXX) rose 18.87% to $1.26 during Friday's pre-market session. Only yesterday these shares were declining by -25.35%, so we see a bit of recovery today. Two days ago the company had a press release: Bright Green Announces Plans to Raise $500 Million Under EB-5 Capital Program.
AWH15.41%ASPIRA WOMEN'S HEALTH INC's (NASDAQ:AWH) stock price is advancing with 15.41% to a price of $0.51. NASDAQ:AWH seems to be recovering from a -13.73% loss in the previous session.
QTEK14.61%QUALTEK SERVICES INC-A's (NASDAQ:QTEK) stock price is advancing with 14.61% to a price of $0.47. Prices are quite volatile here as yesterday NASDAQ:QTEK closed with a -14.58% loss.
SONM13.21%SONIM TECHNOLOGIES INC (NASDAQ:SONM) rose 13.21% to $0.6 during Friday's pre-market session. In the last 3 months the share price increased with 20.51%.

For the full premarket gainers list go to our premarket gainers screener.

Pre-market losers

TickerChangeComment
EDBL-44.31%EDIBLE GARDEN AG INC's (NASDAQ:EDBL) stock price is declining with 44.31% to a price of $4.65. Yesterday's drop of -28.63% continued in today's pre-market session with another decline of 44.31% Yesterday the company had a press release: Edible Garden Announces Pricing of Upsized $10.2 Million Underwritten Public Offering.
DNA.W-37.21%GINKGO BIOWORKS -CW27's (NYSE:DNA.W) shares fell 37.21% to $0.18 during Friday's pre-market session. NYSE:DNA.W already had a hard day yesterday: closing -11.1% lower during the regular session.
VINO-37.04%GAUCHO GROUP HOLDINGS INC's (NASDAQ:VINO) stock price decreased by 37.04% to $3.4. Prices are quite volatile now: this is a reversal from yesterday's 339.0% gain.
TENX-28.51%TENAX THERAPEUTICS INC's (NASDAQ:TENX) stock price is declining with 28.51% to a price of $1.58. After running up 30.77% in yesterday's session, NASDAQ:TENX is pulling back pre-market.
SMMT-27.84%SUMMIT THERAPEUTICS INC's (NASDAQ:SMMT) shares fell 27.84% to $2.8. In the last month the stock lost 28.28%.
CLLS-24.54%CELLECTIS - ADR's (NASDAQ:CLLS) stock price decreased by 24.54% to $2.46. A press release (Cellectis Announces Pricing of Follow-On Offering) was released earlier today.
BILL-21.34%BILL.COM HOLDINGS INC's (NYSE:BILL) stock price is declining with 21.34% to a price of $101.4. A press release (BILL Reports Second Quarter Fiscal Year 2023 Financial Results) was released yesterday.
IVC-19.67%INVACARE CORP's (NYSE:IVC) stock price is declining with 19.67% to a price of $0.53. A press release (Invacare Corporation Takes Action to Strengthen Its Financial Position and Drive Long-Term Growth Through Voluntary Prearranged Chapter 11 Cases That Do Not Include Its International Operations) was released two days ago.
SNCE-18.1%SCIENCE 37 HOLDINGS INC's (NASDAQ:SNCE) stock price is declining with 18.1% to a price of $0.51. After yesterdays gain of 15.18%, it goes down with 18.1% in today's pre-market session. A press release (Science 37 Acquires Vault Health’s Life Sciences Platform To Bolster its Metasite Capabilities) was released yesterday.
HLBZW-13.79%HELBIZ INC-CW24's (NASDAQ:HLBZW) shares fell 13.79% to $0.05. Shareholders saw the stock price going 29.18% higher in the past 3 months.

To see the full list of premarket losers you can use our premarket losers screener.

Back

TENAX THERAPEUTICS INC

NASDAQ:TENX (4/19/2024, 7:19:11 PM)

3.63

-0.05 (-1.36%)

TENX News

News Image2 days ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Pre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Thursday morning!

News Image11 days ago - Tenax TherapeuticsTenax Therapeutics to Host KOL Event: “LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study”

Panel of renowned cardiologists, all globally recognized experts in heart failure, will discuss the unmet medical need in pulmonary hypertension due to...

News Image22 days ago - InvestorPlaceTENX Stock Earnings: Tenax Therapeutics Misses EPS for Q4 2023

TENX stock results show that Tenax Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.

News Image22 days ago - BusinessInsiderTENX Stock Earnings: Tenax Therapeutics Misses EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Tenax Therapeutics (NASDAQ:TENX) just reported results for the fourth quarter o...

News Image23 days ago - Tenax TherapeuticsTenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial Results

First Patient Enrolled in Phase 3 LEVEL Trial Evaluating TNX-103 (oral levosimendan) for the Treatment of Pulmonary Hypertension from Heart Failure with...

News Imagea month ago - Tenax TherapeuticsTenax Therapeutics to Present at the 36th Annual Roth Conference

CHAPEL HILL, N.C., March 12, 2024 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX), a Phase 3, development-stage pharmaceutical company...

News Image2 months ago - Tenax TherapeuticsTenax Therapeutics Announces Oral Presentation of Levosimendan for the Treatment of PH-HFpEF at THT 2024

Dr. Sanjiv Shah, a renowned, global expert in the treatment of HFpEF and PH-HFpEF, will present data highlighting the use of levosimendan for the treatment...

News Image2 months ago - Tenax TherapeuticsTenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan

Amendment to existing exclusive license agreement with Orion Corporation expands Tenax’s territory rights from North America, to the entire worldExpanded...

News Image2 months ago - InvestorPlaceACB Stock Alert: The $50 Million Reason Aurora Cannabis Is Up Today

Aurora Cannabis stock is rising higher on Thursday as ACB investors react to the company acquiring MedReleaf Australia for $50 million.

News Image2 months ago - InvestorPlaceWhy Is Disney (DIS) Stock Up 9% Today?

Disney stock is gaining on Thursday as investors in DIS shares celebrate the company's strong earnings report for the first quarter of 2024.

News Image2 months ago - InvestorPlaceWhy Is Tenax Therapeutics (TENX) Stock Down 64% Today?

Tenax Therapeutics stock is falling on Thursday after the company announced the pricing of a public offering for TENX shares.

TENX Links
Follow us for more